Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Oncternal Therapeutics Inc (ONCT)

NASDAQ
Currency in USD
Disclaimer
8.5600
+0.0100(+0.12%)
Closed

ONCT Comments

250m usd company? This should be bought at 3 billion.
Excellent data readout! Prepare for a buyout in 2021. HOLD and add some more if you can.
test
This one could be yummy
But, I'm surprised NOW.
Won't be surprised if ONCT hit $4 before end of January 2021.
WHAT'S UP. Why dropped so much AH?😅
why drop ?
wow, pending defence deal.
they way overvalued for a research company. they got no revenue.
I'm in for 1K shares @1.77...should get to $3-4 imo short term.
The news said their only product tanked in trial. Not whole true. 2 more cancer meds in the works, the trial was not terrible, just inconclusive. Does not = an 80% drop to me. I'm buying in to a rebound.
I had the sane thought buy now while its down. I heard they're in trial for Prostate cancer research now..
Yes me !
Anyone else interested in this ?
What do you think happens next week?
Not really sure wondering that myself
I see a break through coming.
Id say great tune to buy it went down way too fast lol had too @billsmith
I think there is high potential for this stock to rebound
should we buy?
should we buy?
Great time to short up to fast
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.